PRICE T ROWE ASSOCIATES INC /MD/ - AMBRX BIOPHARMA INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of AMBRX BIOPHARMA INC
ValueSharesWeighting
Q3 2023$9,448
-38.2%
821,564
-11.6%
0.00%
-50.0%
Q2 2023$15,297
+714.1%
929,317
+341.2%
0.00%
Q1 2023$1,879210,6270.00%
Other shareholders
AMBRX BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,486,386$22,452,0001.34%
Fosun International Ltd 1,932,591$17,451,0001.00%
Octagon Capital Advisors LP 336,868$3,042,0000.59%
Artal Group S.A. 2,152,291$19,435,0000.53%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,057,735$9,551,0000.18%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,923,700$17,371,0000.03%
FMR LLC 3,855,025$34,811,0000.00%
TUDOR INVESTMENT CORP ET AL 20,143$182,0000.00%
CAAS CAPITAL MANAGEMENT LP 13,068$118,0000.00%
BlackRock Inc. 2,869,486$25,912,0000.00%
View complete list of AMBRX BIOPHARMA INC shareholders